Profil
Yoni Livne is currently the Chief Financial Officer at Bonus Biogroup Ltd. He previously worked as the Chief Financial Officer at Real Imaging Holdings Ltd. and as the Chief Controller at Dexcel Pharma Technologies Ltd. Livne received an undergraduate degree and an MBA from The Hebrew University of Jerusalem.
Aktive Positionen von Yoni Livne
| Unternehmen | Position | Beginn |
|---|---|---|
| BONUS BIOGROUP LTD. | Finanzdirektor/CFO | 01.06.2014 |
Ehemalige bekannte Positionen von Yoni Livne
| Unternehmen | Position | Ende |
|---|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes generic pharmaceuticals products | Comptroller/Controller/Auditor | - |
Real Imaging Holdings Ltd.
Real Imaging Holdings Ltd. Medical SpecialtiesHealth Technology Develops imaging and cancer detection devices for the treatment of breast cancer | Finanzdirektor/CFO | - |
Ausbildung von Yoni Livne
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Bonus Biogroup Ltd.
Bonus Biogroup Ltd. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops regeneration therapies and biotechnology products for bones | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Real Imaging Holdings Ltd.
Real Imaging Holdings Ltd. Medical SpecialtiesHealth Technology Develops imaging and cancer detection devices for the treatment of breast cancer | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes generic pharmaceuticals products | Health Technology |
















